Considerations for Time-limited Treatment in 1L Treatment Selection Decisions
Navigating the Complexities of Sickle Cell Disease: An Expert Perspective
IgAN Insights: The Potential Role of the Complement System in Disease Progression
Jean Francis, MD
PeerIdentifying Patients at High-Risk for IgAN Progression: Key Factors to Know
Exploring Early Usage of a 2L ITP Treatment Option: Clinical Profile and Access Resources
Managing Refractory Cytomegalovirus Post-Solid Organ Transplant
Investigating HLH: Our Current Understanding of a Rare Disease
Managing Refractory Cytomegalovirus After Hematopoietic Cell Transplant
Understanding Individualized Treatment Goals for gMG
Beth Stein, MD
PeerUnderstanding the Key Role of FcRn in Anti-AChR Antibody Positive gMG
Nicholas J. Silvestri, MD, FAAN
PeerExamining 2 Treatment Options for Anti-AChR Antibody Positive gMG: An Overview of the Trial Designs
Charulatha P. Nagar, MD
PeerInvestigating Imaging Techniques in Multiple Myeloma